1995 Study Finds Estrogen Increases 5-HT2A Receptor Density in the Female Rat Brain
The increase was seen primarily in the cerebral cortex and the nucleus accumbens.
Articles by Barb Bauer
Scientists Discover a New Cannabinoid in Cannabis sativa: Δ9-THCP
Tetrahydrocannabiphorol could account for the pharmacological properties of some cannabis varieties which are difficult to explain by the presence of THC alone.
The Medical University of South Carolina is Launching a Psychedelic Research Center
Scheduled to open in 2021, the new center will study the therapeutic potential of MDMA, psilocybin, DMT, and mescaline.
Eleusis’s Phase I Alzheimer’s Trial Finds Favorable Safety & Tolerability of LSD in Older Volunteers
There were no abnormalities or deviations in safety or cognitive outcome measures compared to the baseline data.
What is Kratom?
It is a plant that contains over 40 alkaloid and non-alkaloid compounds, some of which have analgesic and psychoactive properties.
What is Ibogaine?
Ibogaine is a compound found in the leaves of an African shrub called Iboga, and studies indicate it may have anti-addictive properties.
Scientists Test the Effects of Inhaling Synthetic 5-MeO-DMT
Some changes occured to biomarkers for stress and inflammation. The subjective effects reveal more evidence of the entourage effect.
COMPASS Patent Highlights Importance of Crystallography in Psychedelic Drug Development
The scope and validity of this patent will depend on how x-ray diffraction data is interpreted.
Placebo-Controlled Study Finds Psilocybin Formulation is Safe and Well-Tolerated in Healthy Volunteers
The study used an investigational psilocybin formulation called COMP360 developed and produced by COMPASS Pathways.
Study Identifies Compounds and Mechanism that Causes Psilocybin Mushroom Bluing
These bluing compounds can exist as dimeric, trimeric, and tetrameric forms of psilocin and/or its structural analogs.